Curriculum Vitae

PERSONAL DETAILS

DATO' PROF. DR. ADEEBA BINTI KAMARULZAMAN

  • Professor

  • Department of Medicine
    Faculty of Medicine
  •    +603-79492050
  •   adeeba@um.edu.my

BIOGRAPHY

Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and an Adjunct Associate Professor at Yale University, USA. She established the Centre of Excellence for Research on AIDS (CERiA) that conducts multi-disciplinary research on HIV ranging from clinical to public health and policy research.

Professor Kamarulzaman has used her clinical and academic leadership to engage in the national and community response to HIV/AIDS. She is currently Chairman of the Malaysian AIDS Foundation and an Executive Council member of the Malaysian AIDS Council, the peak HIV NGO in Malaysia.

At the international level, Professor Kamarulzaman is presently an Executive Council Member of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV. She has also been an advisor to numerous WHO committees on HIV/AIDS. She has played a key role in the establishment and ongoing activities and collaborations of a regional HIV research network initiative; TREAT Asia.

Her achievements have been recognised through several national and international awards including the Tun Mahathir Science and the Merdeka Awards for her role as a member of the University of Malaya’s Nipah Investigative Team. She is the first recipient of the Advance Australia Global Award in the category of Alumni in 2012 and in April 2015 she was honoured with a Doctor of Laws (honoris causa) from her alma mater, Monash University. She also has the distinct honour of having been featured in both The Lancet and Science publications in 2013 and 2014 respectively.

 

ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Head of Unit, UNIVERISITI MALAYA, 01/01/2020 to present
  • Senate member, University Malaya, University Malaya, 01/08/2010 to present
  • Dean, UNIVERISITI MALAYA, 03/12/2018 to 02/12/2020
  • AHLI MAJLIS PENASIHAT KESIHATAN, University Malaya, 09/11/2018 to 08/11/2020
  • Head of Unit, UNIVERISITI MALAYA, 01/01/2018 to 31/12/2019
  • Dean, UNIVERISITI MALAYA, 11/10/2018 to 02/12/2018
  • Exercising The Function of Dean, UNIVERISITI MALAYA, 01/07/2018 to 10/10/2018
  • Dean, UNIVERISITI MALAYA, 01/07/2016 to 30/06/2018
  • Head of Unit, UNIVERISITI MALAYA, 01/01/2016 to 31/12/2017
  • Dean, UNIVERISITI MALAYA, 01/07/2014 to 30/06/2016
  • Head of Unit, UNIVERISITI MALAYA, 01/01/2015 to 31/12/2015
  • Ahli Lembaga Pengurus Pusat Perubatan University Malaya, University Malaya, 20/04/2015 to present
  • Ahli Lembaga Penasihat CIC, University Malaya, 09/02/2015 to present
  • Head of Unit, UNIVERISITI MALAYA, 02/01/2014 to 31/12/2014
  • Dean, UNIVERISITI MALAYA, 01/07/2012 to 30/06/2014
  • Dean, UNIVERISITI MALAYA, 01/07/2011 to 30/06/2012
  • Chair - Infection Control Committee , UMMC, University Malaya, 01/01/2006 to 31/12/2011
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • FRACP(1995) (AUS), PERUBATAN, ROYAL AUSTRALIASIAN COLLEGE OF PHYSICIANS
  • MBBS, PERUBATAN DAN PEMBEDAHAN, MONASH UNIVERSITY, AUSTRALIA
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • International AIDS Society , 1st Vice President, 2018 to 2020 (International)
  • Ahli Jawatankuasa Pengajian Program Doktor Perubatan, Fakulti Perubatan dan Sains Kesihatan, Committee Member, 2018 to 2021 (National)
  • Merdeka Award Secretariat, Committee, 2018 to 2020 (National)
  • Academy of Medicine Malaysia, Others, 2017 to 2018 (National)
  • World Health Organization, Expert Panel Member, 2017 to 2021 (International)
  • Majlis Perubatan Malaysia, Panel Member, 2017 to 2017 (National)
  • Academy of Science Malaysia , Active Member, Since 2016 (National)
  • Academy of Medicine, Academic Committee Member, Since 2015 (National)
  • Malaysian Medical Association , Active Member, Since 2014 (National)
SPECIALIZATION
(Area)
Area of Expertise
  • INFECTIOUS/COMMUNICABLE DISEASES (Specialist In Infectious Diseases NSR)
  • INFECTIOUS/COMMUNICABLE DISEASES
  • PUBLICATIONS
    (Title of publication in APA style)
    Refereed Journals
    2021
    • Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution Kim Tien Ng, Yutaka Takebe, Adeeba Kamarulzaman & Kok Keng Tee (ISI-Indexed)
    • Rebecca T Henry 1, Awachana Jiamsakul 1, Matthew Law 1, Marcelo Losso 2, Adeeba Kamarulzaman 3, Praphan Phanuphak 4, Nagalingeswaran Kumarasamy 5, Sharne Foulkes 6, Lerato Mohapi 7, Chidi Nwizu 8, Robin Wood 9, Anthony Kelleher 1, Mark Polizzotto 1, SECOND-LINE Study Group . Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants (ISI-Indexed)
    • Kim Sui Wan 1 2, Peter Seah Keng Tok 1 2, Kishwen Kanna Yoga Ratnam 1 2, Nuraini Aziz 1 2, Marzuki Isahak 1, Rafdzah Ahmad Zaki 1, Nik Daliana Nik Farid 1, Noran Naqiah Hairi 1, Sanjay Rampal 1, Chiu-Wan Ng 1, Mohd Fauzy Samsudin 1 2, Vinura Venugopal 1 2, Mohammad Asyraf 1 2, Narisa Hatun Damanhuri 1 2, Sanpagavalli Doraimuthu 1 2, Catherine Thamarai Arumugam 1 2, Thaneswaran Marthammuthu 1 2, Fathhullah Azmie Nawawi 1 2, Faiz Baharudin 1 3, Diane Woei Quan Chong 1 2, Vivek Jason Jayaraj 1 2, Venna Magarita 3, Sasheela Ponnampalavanar 3 4, Nazirah Hasnan 3 5, Adeeba Kamarulzaman 3 4, Mas Ayu Said 1. Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country (ISI-Indexed)
    • Stefan David Baral # 1, Katherine Blair Rucinski # 1, Jean Olivier Twahirwa Rwema # 1, Amrita Rao # 1, Neia Prata Menezes # 1, Daouda Diouf # 2, Adeeba Kamarulzaman # 3, Nancy Phaswana-Mafuya # 4, Sharmistha Mishra # 5. The Relationship Between the Global Burden of Influenza From 2017 to 2019 and COVID-19: Descriptive Epidemiological Assessment (ISI-Indexed)
    • Susan C S Chong 1, Adeeba Kamarulzaman 2, Iskandar Azwa 3, Rong-Xiang Ng 3, Meng-Li Chong 4, Nishaan Raman 3, Adam Bourne 5. Delayed HIV testing and treatment seeking, and associated support needs among people living with HIV in Malaysia: a qualitative study (ISI-Indexed)
    • Commissioners of and collaborators with the International AIDS Society Lancet Commission on Health and Human Rights. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights (ISI-Indexed)
    • Archana Krishnan 1, Damian Weikum 2, Claire Cravero 3, Adeeba Kamarulzaman 4, Frederick L Altice 2 4 5. Assessing mobile technology use and mHealth acceptance among HIV-positive men who have sex with men and transgender women in Malaysia (ISI-Indexed)
    • Melinda Wang 1, Sin How Lim 2 3, Britton A Gibson 4, Iskandar Azwa 5, Thomas E Guadamuz 6, Frederick L Altice 1 2 7, Adeeba Kamarulzaman 1 2, Jeffrey A Wickersham 1 2. Correlates of newly diagnosed HIV infection among cisgender women sex workers and transgender women sex workers in Greater Kuala Lumpur, Malaysia (ISI-Indexed)
    • Balasingam Vicknasingam 1, Nur Afiqah Mohd Salleh 2 3, Weng-Tink Chooi 4, Darshan Singh 1, Norzarina Mohd Zaharim 4, Adeeba Kamarulzaman 3 5, Marek C Chawarski 6. COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia (ISI-Indexed)
    • Teri Roberts 1, Suvanand Sahu 2, James Malar 2, Timur Abdullaev 3, Wim Vandevelde 4, Yogan G Pillay 5, Paula I Fujiwara 6, Alasdair Reid 7, Shannon Hader 7, Satvinder Singh 8, Adeeba Kamarulzaman 1 9, Sevim Ahmedov 10. Turning threats into opportunities: how to implement and advance quality TB services for people with HIV during the COVID-19 pandemic and beyond (ISI-Indexed)
    • Sean Tackett 1, Jeremy Sugarman 2 3, Chirk Jenn Ng 4, Adeeba Kamarulzaman 5, Joseph Ali 2. Developing a competency framework for health research ethics education and training (ISI-Indexed)
    • Stefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, Carrie Lyons, Muge Cevik, Anna E K gesten, Daouda Diouf, Annette H Sohn, Refilwe Phaswana-Mafuya, Adeeba Kamarulzaman, Gregorio Millett, Julia L Marcus, Sharmistha Mishra . Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review (ISI-Indexed)
    2020
    • Annette H Sohn 1, Nittaya Phanuphak 2, Stefan Baral 3, Adeeba Kamarulzaman 4. Know your epidemic, know your response: understanding and responding to the heterogeneity of the COVID-19 epidemics across Southeast Asia (ISI-Indexed)
    • Meng Li, C., Jie Ying, F., Raj, D., Pui Li, W., Kukreja, A., Omar, S. F., Kamarulzaman, A., & Rajasuriar, R. (2020). A retrospective analysis of the care cascades for non-communicable disease and mental health among people living with HIV at a tertiary-care centre in Malaysia: opportunities to identify gaps and optimize care. Journal of the International AIDS Society, 23(11), e25638. https://doi.org/10.1002/jia2.25638 (ISI-Indexed)
    • Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey Joris Hemelaar 1, Ramyiadarsini Elangovan 2, Jason Yun 2, Leslie Dickson-Tetteh 2, Shona Kirtley 3, Eleanor Gouws-Williams 4, Peter D Ghys 5, WHO-UNAIDS Network for HIV Isolation and Characterisation (ISI-Indexed)
    • Sophia Archuleta 1 2, Po Ying Chia 3 4 5, Yuan Wei 6, Sharifah F Syed-Omar 7, Jenny G Low 8 9, Helen M Oh 2 10, Dale Fisher 1 2, Sasheela S L Ponnampalavanar 7, Limin Wijaya 8, Adeeba Kamarulzaman 7, Lucy C S Lum 7, Paul A Tambyah 1 2, Yee-Sin Leo 2 3 4 5 11, David C Lye 2 3 4 5 . Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study (ISI-Indexed)
    • Chong YM, Sam IC, Chong J, Kahar Bador M, Ponnampalavanar S, Syed Omar SF, Kamarulzaman A, Munusamy V, Wong CK, Jamaluddin FH, Chan YF. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia. PLoS Neglected Tropical Diseases 2020; 14: e0008744. doi: 10.1371/journal.pntd.0008744 (ISI-Indexed)
    • Abdul W Ansari 1 2 3, Fareed Ahmad 4 5 6, Esaki M Shankar 2 7, Yean K Yong 8, Hong Y Tan 9, Roland Jacobs 4, Marie Larsson 10, Vijayakumar Velu 11, Adeeba Kamarulzaman 1 2, Reinhold E Schmidt 4. Brief Report: Diminished Coinhibitory Molecule 2B4 Expression Is Associated With Preserved iNKT Cell Phenotype in HIV Long-Term Nonprogressors (ISI-Indexed)
    • D Rupasinghe 1, S Kiertiburanakul 2, A Kamarulzaman 3, F Zhang 4, N Kumarasamy 5, R Chaiwarith 6, T P Merati 7, C D Do 8, S Khusuwan 9, A Avihingsanon 10, M P Lee 11, P S Ly 12, E Yunihastuti 13, K V Nguyen 14, R Ditangco 15, Y J Chan 16, S Pujari 17, O T Ng 18, J Y Choi 19, Blh Sim 20, J Tanuma 21, S Sangle 22, J Ross 23, M Law 1. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific (ISI-Indexed)
    • James H McMahon 1, Jennifer F Hoy 2, Adeeba Kamarulzaman 3, Linda-Gail Bekker 4, Chris Beyrer 5, Sharon R Lewin 6 .Leveraging the advances in HIV for COVID-19 (ISI-Indexed)
    • Giovanni Guaraldi 1, Jovana Milic 1 2, Esteban Martinez 3, Adeeba Kamarulzaman 4, Cristina Mussini 1, Laura Waters 5, Anton Pozniak 6, Patrick Mallon 7, J rgen Rockstroh 8, Jeffrey V Lazarus 9. HIV care models during the COVID-19 era (ISI-Indexed)
    • Repurposing Antimalarials to Tackle the COVID-19 Pandemic Sanjeev Krishna,1,6, Yolanda Augustin,1 Jigang Wang,2,3,4 Chengchao Xu,3 Henry M. Staines,1 Hans Platteeuw,5 Adeeba Kamarulzaman,7 Amadou Sall,8 and Peter Kremsner6,9 (ISI-Indexed)
    • Rema Panickar 1 2, Wee Kee Wo 1, Norleen M Ali 1, Min Moon Tang 3, G R Letchuman Ramanathan 4, Adeeba Kamarulzaman 2, Zoriah Aziz 2 5. Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia (ISI-Indexed)
    • Mohd Sani, N., Aziz, Z. & Kamarulzaman, A. Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects. Therapeutic Innovation & Regulatory Science (2020).10.1007/s43441-020-00243-y (ISI-Indexed)
    • Chong DWQ, Jayaraj VJ, Rampal S, Said MA, Nik Farid ND, Ahmad Zaki R, Hairi NN, Hoe VCW, Isahak M, Ponnampalavanar S, Syed Omar SF, Sam IC, Hasnan N, Ong HC, Kamarulzaman A, Ng CW. Establishment of a hospital-based health care workers surveillance programme to keep them safe during the COVID-19 pandemic. Journal of Global Health 2020; 10: 1-3. doi: 10.7189/jogh.10.0203100 (ISI-Indexed)
    2019
    • Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD; WHO UNAIDS Network for HIV Isolation Characterisation. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019 Feb;19(2):143-155. (ISI-Indexed)
    • Jiamsakul A, Polizzotto M, Wen-Wei Ku S, Tanuma J, Hui E, Chaiwarith R, Kiertiburanakul S, Avihingasanon A, Yunihastuti E, Kumarasamy N, Ly PS, Pujari S, Ditangco R, Do CD, Merati TP, Kantipong P, Zhang F, Van Nguyen K, Kamarulzaman A, Choi JY, Sim BLH, Ng OT, Ross J, Wong W. Brief Report: Malignancies in Adults Living With HIV in Asia. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):301-307. doi: 10.1097/QAI.0000000000001918. PubMed PMID: 30531303; PubMed Central PMCID: PMC6375805. (ISI-Indexed)
    • Pasayan MKU, S Mationg ML, Boettiger D, Lam W, Zhang F, Ku SW, Merati TP, Chaiwarith R, Cuong DD, Yunihastuti E, Kiertiburanakul S, Van Kinh N, Avihingsanon A, Sun LP, Kamarulzaman A, Kantipong P, Kumarasamy N, Pujari S, Heng Sim BL, Ng OT, Choi JY, Tanuma J, Ross J, A Ditangco R. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):436-443. doi: 10.1097/QAI.0000000000001933. PubMed PMID: 30550488; PubMed Central PMCID: PMC6391185. (ISI-Indexed)
    • Kamarulzaman A, Verster A, Altice FL. Prisons: ignore them at our peril. Curr Opin HIV AIDS. 2019 Sep;14(5):415-422. (ISI-Indexed)
    • Archuleta S, Chia PY, Wei Y, Syed-Omar SF, Low JG, Oh HM, Fisher D, Ponnampalavanar SSL, Wijaya L, Kamarulzaman A, Lum LCS, Tambyah PA, Leo YS, Lye DC. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. Clin Infect Dis. 2019 Oct 18. (ISI-Indexed)
    • Ahn MY, Jiamsakul A, Khusuwan S, Khol V, Pham TT, Chaiwarith R, Avihingsanon A, Kumarasamy N, Wong WW, Kiertiburanakul S, Pujari S, Nguyen KV, Lee MP, Kamarulzaman A, Zhang F, Ditangco R, Merati TP, Yunihastuti E, Ng OT, Sim BLH, Tanuma J, Ratanasuwan W, Ross J, Choi JY; IeDEA Asia-Pacific. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019 Feb;22(2):e25228. (ISI-Indexed)
    • Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc. 2019 Mar;22(3):e25264. (ISI-Indexed)
    • Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, Wong WW, Kamarulzaman A, Kantipong P, Avihingsanon A, Nguyen KV, Tanuma J, Ng OT, Sim BL, Merati TP, Choi JY, Ditangco R, Yunihastuti E, Sun LP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD). Antivir Ther. 2019;24(4):271-279. (ISI-Indexed)
    • Shrestha R, Lim SH, Altice FL, Copenhaver M, Wickersham JA, Saifi R, Ab Halim MA, Naning H, Kamarulzaman A. Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks. J Community Health. 2019 Aug 2. (ISI-Indexed)
    • Tee YC, Earnshaw VA, Altice FL, Jin H, Kamarulzaman A, Wickersham JA. Evaluating Physicians' Intention to Discriminate Against Patients Living with HIV in Malaysia. AIDS Behav. 2019 Apr;23(4):1039-1047. (ISI-Indexed)
    • Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, Wong WW, Avihingsanon A, Sun LP, Yunihastuti E, Pujari S, Do CD, Merati TP, Kantipong P, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Ng OT, Sim B, Ross J, Kiertiburanakul S; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8. PubMed PMID: 30620108; PubMed Central PMCID: PMC6422532. (ISI-Indexed)
    • Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim BL, Sun LP, Van Nguyen K, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A; IeDEA Asia-Pacific. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region. J Int AIDS Soc. 2019 Jan;22(1):. (ISI-Indexed)
    • Pham MD, Haile BA, Azwa I, Kamarulzaman A, Raman N, Saeidi A, Kahar Bador M, Tan M, Zhu J, Feng Y, Elliott JH, Garcia ML, Li F, Crowe SM, Luchters S, Anderson DA. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study. J Clin Microbiol. 2019 (ISI-Indexed)
    • Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia.AIDS Educ Prev. 2019 Jun;31(3):193-205. doi: 10.1521/aeap.2019.31.3.193. (ISI-Indexed)
    • Chandra DK, Bazazi AR, Nahaboo Solim MA, Kamarulzaman A, Altice FL, Culbert GJ. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia. HIV Res Clin Pract. 2019 Feb;20(1):12-23. (ISI-Indexed)
    • Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia. AIDS Educ Prev. 2019 Jun;31(3):193-205. (ISI-Indexed)
    • Lall P, Saifi R, Baggio D, Schoenberger SF, Choo M, Gilbert L, West B, El-Bassel N, Kamarulzaman A. Risk Factors for a Positive Hepatitis C Status in Fishermen in Kuantan Malaysia. Asia Pac J Public Health. 2019 Apr;31(3):227-237. (ISI-Indexed)
    • Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP, Ly PS, Yunihastuti E, Kumarasamy N, Kamarulzaman A, Tanuma J, Zhang F, Choi JY, Kantipong P, Sim B, Ross J, Law M, Merati TP; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Aug;20(7):439-449. (ISI-Indexed)
    2018
    • Azzeri A, Shabaruddin FH, , Tan SS, Dahlui M, McDonald SA, Kamarulzaman A, Mohamed R. CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION AT INITIAL PRESENTATION TO TERTIARY CARE IN AN ASIAN MIDDLE-INCOME COUNTRY (ISI-Indexed)
    • McDonald SA, Azzeri A, Shabaruddin FH, Dahlui M, Tan SS, Kamarulzaman A, Mohamed R. Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040. Appl Health Econ Health Policy. 2018 Aug 25. doi: 10.1007/s40258-018-0425-3. (ISI-Indexed)
    • Lim SH, Brown SE, Shaw SA, Kamarulzaman A, Altice FL, Beyrer C. "You Have to Keep Yourself Hidden": Perspectives From Malaysian Malay-Muslim Men Who Have Sex With Men on Policy, Network, Community, and Individual Influences on HIV Risk. J Homosex. 2018 Oct 11:1-23. (ISI-Indexed)
    • Rutledge R, Morozova O, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia. LGBT Health. 2018 Nov/Dec;5(8):484-493. doi: . Epub 2018 Nov 27. (ISI-Indexed)
    • Abdul Aziz SA, Mcstea M, Ahmad Bashah NS, Chong ML, Ponnampalavanar S, Syed Omar SF, Sulaiman H, Azwa I, Tan MP, Kamarulzaman A, Rajasuriar R, Kamaruzzaman SB. Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment. AIDS. 2018 May 15;32(8):1025-1034. (ISI-Indexed)
    • Oong XY, Chook JB, Ng KT, Chow WZ, Chan KG, Hanafi NS, Pang YK, Chan YF, Kamarulzaman A, Tee KK. The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults. Virol J. 2018 May 23;15(1):91. (ISI-Indexed)
    • Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018 Jul 28;392(10144):312-358. (ISI-Indexed)
    • Ng KT, Oong XY, Lim SH, Chook JB, Takebe Y, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Viral Load and Sequence Analysis Reveal the Symptom Severity, Diversity, and Transmission Clusters of Rhinovirus Infections. Clin Infect Dis. 2018 Jul 2;67(2):261-268. (ISI-Indexed)
    • Naning H, Al-Darraji HAA, McDonald S, Ismail NA, Kamarulzaman A. Modelling the Impact of Different Tuberculosis Control Interventions on the Prevalence of Tuberculosis in an Overcrowded Prison. Asia Pac J Public Health. 2018 Apr;30(3):235-243. (ISI-Indexed)
    • Mukherjee T, Sakthivel R, Fong HY, McStea M, Chong ML, Omar SF, Chin AV, Kamaruzzaman S, Kamarulzaman A, Rajasuriar R, Cysique LA. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia. AIDS Behav. 2018 Oct;22(10):3226-3233. (ISI-Indexed)
    • Mohd Salleh NA, Richardson L, Kerr T, Shoveller J, Montaner J, Kamarulzaman A, Milloy MJ. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. J Addict Med. 2018 Jul/Aug;12(4):308-314. (ISI-Indexed)
    • Barr -Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P. Expert consensus statement on the science of HIV in the context of criminal law. J Int AIDS Soc. 2018 Jul;21(7):e25161. (ISI-Indexed)
    • Vijay A, Earnshaw VA, Tee YC, Pillai V, White Hughto JM, Clark K, Kamarulzaman A, Altice FL, Wickersham JA. Factors Associated with Medical Doctors' Intentions to Discriminate Against Transgender Patients in Kuala Lumpur, Malaysia. LGBT Health. 2018 Jan;5(1):61-68. (ISI-Indexed)
    • Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216. (ISI-Indexed)
    • Stacey A. Shaw, Olivia Cornwell, Sin How Lim, Rumana Saifi, Lik Teng Ung & Adeeba Kamarulzaman. Allah will decide my life and death : Religion and spirituality among populations at risk for HIV in Malaysia (ISI-Indexed)
    • Lee, S.C., Chua, L.L., Yap, S.H., Khang, T.F., Chan, Y.L., Azwa, I., Lewin, S.R., Kamarulzaman, A., Woo, Y.L., Lim, Y.A.L., Loke, P., Rajasuriar, R. (2018). Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals. Scientific Reports, 8:14277. (ISI-Indexed)
    • Lim SH, Akbar M, Wickersham JA, Kamarulzaman A, Altice FL. The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Int J Drug Policy. 2018 May;55:256-262. (ISI-Indexed)
    • Khan F, Krishnan A, Ghani MA, Wickersham JA, Fu JJ, Lim SH, Dhaliwal SK, Kamarulzaman A, Altice FL. Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia. Subst Use Misuse. 2018 Jan 28;53(2):249-259. (ISI-Indexed)
    • Yong YK, Saeidi A, Tan HY, Rosmawati M, Enstr m PF, Batran RA, Vasuki V, Chattopadhyay I, Murugesan A, Vignesh R, Kamarulzaman A, Rajarajeswaran J, Ansari AW, Vadivelu J, Ussher JE, Velu V, Larsson M, Shankar EM. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161(++)TCR iV 7.2(+) Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. Front Immunol. 2018 Mar 19;9:472. (ISI-Indexed)
    2017
    • Sit, P. S., Teh, C. S., Idris, N., Sam, I. C., Syed Omar, S. F., Sulaiman, H., . . . Ponnampalavanar, S. (2017). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect Dis, 17(1), 274. doi:10.1186/s12879-017-2384-y (ISI-Indexed)
    • Rajasuriar, R., Chong, M. L., Bashah, A., Nor, S., Abdul Aziz, S. A., Mcstea, M., ... & Sharifah, F. (2017). Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Aids, 31(10), 1393-1403. (ISI-Indexed)
    • Beyrer C, Kamarulzaman A. Ethnic cleansing in Myanmar: the Rohingya crisis and human rights. Lancet. 2017 Sep 30;390(10102):1570-1573. (ISI-Indexed)
    • Yap SH, Abdullah NK, McStea M, Takayama K, Chong ML, Crisci E, Larsson M, Azwa I, Kamarulzaman A, Leong KH, Woo YL, Rajasuriar R. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. PLoS One. 2017 Oct 9;12(10):e0186000. . (ISI-Indexed)
    • Lye, D. C., Archuleta, S., Syed-Omar, S. F., Low, J. G., Oh, H. M., Wei, Y., ... & Ooi, E. E. (2017). Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. The Lancet, 389(10079), 1611-1618. (ISI-Indexed)
    • Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. . (ISI-Indexed)
    • Oong XY, Ng KT, Takebe Y, Ng LJ, Chan KG, Chook JB, Kamarulzaman A, Tee KK.Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: phylogenetic, spatiotemporal and transmission network analyses. (ISI-Indexed)
    • Naidu, S., Ponnampalvanar, S., Kamaruzzaman, S. B., & Kamarulzaman, A. (2017). Prevalence of metabolic syndrome among people living with HIV in developing countries: a systematic review. AIDS patient care and STDs, 31(1), 1-13. (ISI-Indexed)
    • Leng CY, Low HC, Chua LL, Chong ML, Sulaiman H, Azwa I, Roberts JM, Kamarulzaman A, Rajasuriar R, Woo YL.Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy. (ISI-Indexed)
    • Ahmad F, Shankar EM, Yong YK, Tan HY Ahrenstorf G, Jacobs R, Larsson M, Schmidt RE, Kamarulzaman A, Ansari AW.Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression. (ISI-Indexed)
    • Lim LM, McStea M, Chung WW, Nor Azmi N, Abdul Aziz SA, Alwi S, Kamarulzaman A, Kamaruzzaman SB,Chua SS, Rajasuriar R.Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. (ISI-Indexed)
    • Wegman MP, Altice FL, Kaur S, Rajandaran V, Osornprasop S, Wilson D, Wilson DP, Kamarulzaman A.Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study. (ISI-Indexed)
    • Tee KK, Bon AH, Chow WZ, Ng KT, Chan KG, Kamarulzaman A, Busch MP, Takebe Y. Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia. Genome Announc. 2017 Jun 29;5(26). pii: e00459-17. doi: . PubMed PMID: 28663289; PubMed Central PMCID: PMC5638273. (ISI-Indexed)
    • Wickersham JA, Gibson BA, Bazazi AR, Pillai V, Pedersen CJ, Meyer JP, El-Bassel N, Mayer KH, Kamarulzaman A, Altice FL. Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study. Sex Transm Dis. 2017 Nov;44(11):663-670. (ISI-Indexed)
    • Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). J Int AIDS Soc. 2017 Dec;20(4). (ISI-Indexed)
    • Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Int J Drug Policy. 2017 Sep;47:144-152. (ISI-Indexed)
    • Lall P, Shaw SA, Saifi R, Sherman S, Azmi NN, Pillai V, El-Bassel N, Kamarulzaman A, Wickersham JA. Acceptability of a microfinance-based empowerment intervention for transgender and cisgender women sex workers in Greater Kuala Lumpur, Malaysia. J Int AIDS Soc. 2017 Aug 2;20(1):21723. (ISI-Indexed)
    • Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD). Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther. 2017 May 5;14:27. (ISI-Indexed)
    • Bazazi AR, Vijay A, Crawford FW, Heimer R, Kamarulzaman A, Altice FL. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. AIDS Care. 2018 Jan;30(1):59-64. (ISI-Indexed)
    2016
    • Ng KT, Chook JB, Oong XY, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Performance of a Taqman assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855. (ISI-Indexed)
    • Chow WZ, Chan YF, Oong XY, Ng LJ, Nor E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016; 6:27730. (ISI-Indexed)
    • Gender identity, healthcare access, and risk reduction among Malaysia's mak nyah community Britton A. Gibson, Shan-Estelle Brown, Ronnye Rutledge, Jeffrey A. Wickersham, Adeeba Kamarulzaman & Frederick L. Altice (ISI-Indexed)
    • Al-Khannaq, M.N., Ng, K.T., Oong, X.Y., Pang, Y.K., Takebe, Y., Chook, J.B., Hanafi, N.S., Kamarulzaman, A. and Tee, K.K., 2016. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.The American journal of tropical medicine and hygiene, pp.15-0810. (ISI-Indexed)
    • Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK. 2016. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J 2016; 13(1):33. (ISI-Indexed)
    • Earnshaw VA, Jin H, Wickersham JA, Kamarulzaman A, John J, Lim SH, and Altice FL. 2016. Stigma Toward Men Who Have Sex with Men Among Future Healthcare Providers in Malaysia: Would More Interpersonal Contact Reduce Prejudice? AIDS and Behavior Jan;20(1):98-106.DOI 10.1007/s10461-015-1168-x (ISI-Indexed)
    • . Brown SE, Wickersham JA, Pelletier AR, Marcus RM, Erenrich R, Kamarulzaman A, Altice FL.Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs. (ISI-Indexed)
    • Lall P, Saifi R, Kamarulzaman A.Tobacco Consumption Among HIV-Positive Respondents: Findings From the Third Round of the National Family Health Survey. (ISI-Indexed)
    • Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK.Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia. (ISI-Indexed)
    • Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goul o J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mej a D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Z bransk T, Beyrer C.Public health and international drug policy. (ISI-Indexed)
    • Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD).Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD. (ISI-Indexed)
    • Krishnan A, Brown SE, Ghani MA, Khan F, Kamarulzaman A, Altice FL.Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach. (ISI-Indexed)
    • Nasarruddin AM, Saifi RA, Othman S, Kamarulzaman A.Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs. (ISI-Indexed)
    • Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. (ISI-Indexed)
    • Bick J,Culbert G, Al-Darraji HA,Koh C, Pillai V, Kamarulzaman A, Altice F.Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia. (ISI-Indexed)
    • Mukherjee T Wickersham JA, Desai MM, Pillai V, Kamarulzaman A, Altice FL.Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia. (ISI-Indexed)
    • Chow WZ, Bon AH, Keating S, Anderios F, Halim HA, Takebe Y, Kamarulzaman A, Busch MP, Tee KK. Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries. (ISI-Indexed)
    • Zelenev A, Long E, Bazazi AR, Kamarulzaman A, Altice FL.The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling. . (ISI-Indexed)
    • Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL.Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. . (ISI-Indexed)
    • Tanuma J, Jiamsakul A, Makane A, Avihingsanon A, Ng OT, Kiertiburanakul S, Chaiwarith R, Kumarasamy N, Nguyen KV, Pham TT, Lee MP, Ditangco R, Merati TP, Choi JY, Wong WW, Kamarulzaman A, Yunihastuti E, Sim BL, Ratanasuwan W, Kantipong P, Zhang F, Mustafa M, Saphonn V, Pujari S, Sohn AH; TREAT Asia HIV Observational Databases (TAHOD).Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. (ISI-Indexed)
    • Yong YK, Shankar EM, Westhorpe CL, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR.Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy. (ISI-Indexed)
    • Yong YK, Shankar EM, Solomon A, Spelman T, Fairley CK, Elliott JH, Hoy J, Cameron PU, Kamarulzaman A, Lewin SR.Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy. (ISI-Indexed)
    • Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong do D, Lee MP, Sim BL, Phanuphak P, Wong WW, Kamarulzaman A, Zhang F, Pujari S, Chaiwarith R, Oka S, Mustafa M, Kumarasamy N, Van Nguyen K, Ditangco R, Kiertiburanakul S, Merati TP, Durier N, Choi JY; TREAT Asia HIV Observational Databases (TAHOD).Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. (ISI-Indexed)
    • Culbert GJ, Pillai V, Bick J, Al-Darraji HA, Wickersham JA, Wegman MP, Bazazi AR, Ferro E, Copenhaver M, Kamarulzaman A, Altice FL.Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia. (ISI-Indexed)
    • Lunze K, Idrisov B, Golichenko M, Kamarulzaman A.Mandatory addiction treatment for people who use drugs: global health and human rights analysis. (ISI-Indexed)
    • Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K.Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort. (ISI-Indexed)
    • Rahman F, Kamarulzaman A.Southeast Asia in focus: stemming the reawakening of prohibitionism. (ISI-Indexed)
    • Lam EP, Moore CL, Gotuzzo E, Nwizu C, Kamarulzaman A, Chetchotisakd P, van Wyk J, Teppler H, Kumarasamy N, Molina JM, Emery S, Cooper DA, Boyd MA.Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study. (ISI-Indexed)
    • Azanan MS, Abdullah NK, Chua LL, Lum SH, Abdul Ghafar SS, Kamarulzaman A, Kamaruzzaman S, Lewin SR, Woo YL, Ariffin H, Rajasuriar R.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus. . (ISI-Indexed)
    • Beyrer C, Kamarulzaman A, McKee M; Lancet HIV in Prisoners Group.Prisoners, prisons, and HIV: time for reform. (ISI-Indexed)
    • Al-Darraji HA, Altice FL, Kamarulzaman A.Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community. (ISI-Indexed)
    • Michalopoulos LM, Jiwatram-Negr n T, Choo MK, Kamarulzaman A, El-Bassel N.The association between psychosocial and structural-level stressors and HIV injection drug risk behavior among Malaysian fishermen: A cross-sectional study. (ISI-Indexed)
    • Tan HY, Yong YK, Shankar EM, Paukovics G, Elleg rd R, Larsson M, Kamarulzaman A, French MA, Crowe SM.Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (ISI-Indexed)
    2015
    • Oong XY, Ng KT, Lam TTY, Pang YK, Chan KG, Hanafi NS, Kamarulzaman A, Tee KK. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PloS ONE 2015;10(8), p.e0136254 (ISI-Indexed)
    • Ng KT, Oong XY, Pang YK, Hanafi NS, Kamarulzaman A, Tee KK. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging microbes & infections 2015;4(8), p.e47. (ISI-Indexed)
    • Cheong HT, Chow WZ, Takebe Y, Chook JB, Chan KG, Al- Darraji HA, Koh C, Kamarulzaman A, Tee KK. Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. PLoS One. 2015 Jul 21;10(7):e0133883. (ISI-Indexed)
    • Chan KG, Ng KT, Chong TM, Pang YK, Kamarulzaman A, Yin WF, Tee KK. Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing. J Genomics. 2015 Jun 3;3:72-4 (ISI-Indexed)
    • Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance-Monitoring Study TASER-M. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. J Med Virol. 2015 Jul 3. (ISI-Indexed)
    • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
    • Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32 (ISI-Indexed)
    • Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther. 2015 Jun 12 (ISI-Indexed)
    • Chan KG, Ng KT, Pang YK, Chong TM, Kamarulzaman A, Yin WF, Tee KK. Genome Anatomy of Streptococcus parasanguinis Strain C1A, Isolated from a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Reveals Unusual Genomic Features. Genome Announc. 2015 May 28;3(3) (ISI-Indexed)
    • Ansari AW, Ahmad F, Meyer-Olson D, Kamarulzaman A, Jacobs R, Schmidt RE. Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci. 2015 Aug;72(16):3037-49 (ISI-Indexed)
    • Wright ST, Law MG, Cooper DA, Keen P, McDonald A, Middleton M, Woolley I, Kelly M, Petoumenos K; Australian HIV Observational Database. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015 Apr 10;18:19463 (ISI-Indexed)
    • Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat. 2015 Jul;54:29-36. (ISI-Indexed)
    • Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A. Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. (ISI-Indexed)
    • Al-Darraji HA, Tan C, Kamarulzaman A, Altice FL. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med. 2015 Jun;72(6):442-7. (ISI-Indexed)
    • Barathan M, Mohamed R, Saeidi A, Vadivelu J, Chang LY, Gopal K, Ram MR, Ansari AW, Kamarulzaman A, Velu V, Larsson M, Shankar EM. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest. 2015 May;45(5):466-74. (ISI-Indexed)
    • Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2015 Jul;26(7):675-81. (ISI-Indexed)
    • Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS Behav. 2015 Dec;19(12):2347-57. (ISI-Indexed)
    • Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92 (ISI-Indexed)
    • Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS. 2015 May;29(5):229-31.Epub 2015 Mar 16 (ISI-Indexed)
    • Culbert GJ, Waluyo A, Iriyanti M, Muchransyah AP, Kamarulzaman A, Altice FL. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015 Apr 1;149:71-9. (ISI-Indexed)
    • Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co- morbidities among women who use drugs in Malaysia: Important targets for intervention. Addict Behav. 2015 Sep 25;53:31-39. (ISI-Indexed)
    • Tien Ng K, Takebe Y, Bee Chook J, Zhen Chow W, Gan Chan K, Abed Al-Darraji HA, Kamarulzaman A, Keng Tee K. Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep. 2015 Oct 13;5:15198. (ISI-Indexed)
    • Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM. Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. Kaohsiung J Med Sci. 2015 Sep;31(9):445-53. (ISI-Indexed)
    • Tanguay P, Kamarulzaman A, Aramrattana A, Wodak A, Thomson N, Ali R, Vumbaca G, Lai G, Chabungbam A. Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. (ISI-Indexed)
    • Chow WZ, Lim SH, Ong LY, Yong YK, Takebe Y, Kamarulzaman A, Tee KK. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. PLoS One. 2015 Sep 3;10(9):e0137281. (ISI-Indexed)
    • Choo MK, El-Bassel N, Adam PC, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JB, Ismail R, Kamarulzaman A. Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS One. 2015 Aug 5;10(8):e0118422. (ISI-Indexed)
    • Tan, H. Y., Yong, Y. K., Andrade, B. B., Shankar, E. M., Ponnampalavanar, S., Omar, S. F., ... & Crowe, S. M. (2015). Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. Aids, 29(4), 421-431. (ISI-Indexed)
    • Alireza Saeidi1,2, Vicky L. Tien Tien3, Rami Al-Batran4 , Haider A. Al-Darraji2, Hong Y. Tan2,Yean K. Yong2,Sasheela Ponnampalavanar2, Muttiah Barathan1, Devi V. Rukumani1,Abdul W. Ansari2, Vijayakumar Velu5, Adeeba Kamarulzaman2, Marie Larsson6, EsakiM. Shankar1,2* (ISI-Indexed)
    • Sarah Larney, PhD,Bradley M. Mathers, MD,Tonia Poteat, MMSc, MPH, PhD, Adeeba Kamarulzaman k and Louisa Degenhardt, PhD (ISI-Indexed)
    • McDonald SA, Dahlui M, Mohamed R, Naning H, Shabaruddin FH, et al. (2015) Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia. PLoS ONE 10(6): e0128091. doi: 10.1371/journal.pone.0128091 (ISI-Indexed)
    • Lum, L. C., Omar, S. F. S., Ponnampalavanar, S. S. L. S., Tan, L. H., Sekaran, S. D., & Kamarulzaman, A. (2015). Cohorting dengue patients improves the quality of care and clinical outcome. PLoS neglected tropical diseases, 9(6), e0003836. (ISI-Indexed)
    • Lim, M. K., Lai, P. S. M., Ponnampalavanar, S. S. L. S., Omar, S. F. S., Taib, N. A., Yusof, M. Y., ... & Kamarulzaman, A. (2015). Antibiotics in surgical wards: use or misuse? A newly industrialized country s perspective. The Journal of Infection in Developing Countries, 9(11), 1264-1271. (ISI-Indexed)
    2014
    • Harry Jin, Valerie A. Earnshaw, Jeffrey A. Wickersham, Adeeba Kamarulzaman, Mayur M. Desai, Jacob John & Frederick L. Altice 2014. An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV,DOI: 10.1080/09540121.2014.894616 (ISI/SCOPUS Indexed Publication)
    • Ong, L. Y., Razak, S. N. H., Lee, Y. M., Sri La Sri Ponnampalavanar, S., Syed Omar, S. F., Azwa, R. I., ... & Kamarulzaman, A. (2014). Molecular diversity of HIV 1 and surveillance of transmitted drug resistance variants among treatment Na ve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. Journal of medical virology, 86(1), 38-44. (ISI-Indexed)
    • Tan, H. Y., Yong, Y. K., Lim, S. H., Ponnampalavanar, S., Omar, S. F., Pang, Y. K., ... & French, M. A. (2014). Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual health, 11(6), 532-539. (ISI-Indexed)
    2013
    • Reena Rajasuriara,Gabriela Khouryc,Adeeba Kamarulzaman, Martyn A. Frenche,Paul U.Cameronc,and Sharon R. Lewinc
    • Wickersham JA,Zahari MM,Azar MM,Kamarulzaman A,Altice FL
    • Ng KT, Ong LY, Lim SH, Takebe Y, Kamarulzaman A, Tee KK
    • Abed Al-Darraji HA, Abd Razak H, Ng KP, Altice FL, Kamarulzaman A
    • Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N.
    • Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia- Pacific HIV Observational Database (APHOD).
    • Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies.
    • Lim SH, Bazazi AR, Sim C, Choo M, Altice FL, Kamarulzaman A
    • Kamarulzaman A
    • Lee SS, Meintjes G, Kamarulzaman A, Leung CC
    • Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, Lu L, Mahadeva S, Kamarulzaman A, Tee KK.
    • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A
    • Chow WZ, Ong LY, Razak SH, Lee YM, Ng KT, Yong YK, Azmel A, Takebe Y, Al-Darraji HA, Kamarulzaman A, Tee KK
    • Larsson M, Shankar EM, Che KF, Saeidi A, Elleg R, Barathan M, Velu V, Kamarulzaman A.
    • Mohd Zim MA, Sam IC, Omar SF, Cahn YF,Abu Bakar S,Kamarulzaman A. Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2013
    • Lubis R, Bulgiba A, Kamarulzaman A, Hairi NN, Dahlui M, Peramalah D
    2012
    • Sam IC, Karunakaran R, Kamarulzaman A, Ponnampalavanar S, Syed Omar SF, Ng KP, Mohd Yusof MY, Hooi PS, Jafar FL, Abubakar S. A large exposure to Brucella melitensis in a diagnostic laboratory. J Hosp Infect 2012; 80(4):321-5. (ISI-Indexed)
    • Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18.
    • Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-na patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2012 Nov 7
    • Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; On behalf of the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582.
    • Jeffrey A Wickersham,Ruthanne Marcus,Adeeba Kamarulzaman, Muhammad Muhsin Zaharib & Frederick L Altice
    • Al-Darraji HA, Kamarulzaman A, Altice FL. Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. Epub 2012 Mar 7. (ISI-Indexed)
    • Ford N, Singh K, Cooke GS, Mills EJ, von Schoen- Angerer T, Kamarulzaman A, du Cros P. Clin Infect Dis. 2012 May;54(10):1465-72. Epub 2012 Mar 19. (ISI-Indexed)
    • Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P. Tissue Antigens. 2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2. (ISI-Indexed)
    • Tee KK, Kamarulzaman A, Matano T, Takebe Y. Future Virol. (2012) 7(4), 405-414 (ISI-Indexed)
    • Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. PLoS Med. 2012;9(4):e1001207. Epub 2012 Apr 17. (ISI-Indexed)
    • Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217. Epub 2012 Feb 22. (ISI-Indexed)
    • Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1. (ISI-Indexed)
    • Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012) (ISI-Indexed)
    • Ng KT, OngLY, Takabe Y, Kamarulzaman A, Tee KK,
    • Chow WZ, Al-Darraji H, Lee YM, Takebe Y, Kamarulzaman A, Tee KK.
    • Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance
    • Smolak A, Gorroochurn P, Kamarulzaman A, Janjua N
    • Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A,duCros P.
    2011
    • Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French M, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS. 2011 Jul 31;25(12):1455-60
    • Tan LH, Fong MY, Mahmud R, Muslim A, Lau YL, Kamarulzaman A. (2011). Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 60: 111-113 (ISI-Indexed)
    • Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7.
    • Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Robust interferon- nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol. 2011May;139(2):115-21. Epub 2011 Feb 23
    • Kanter J, Koh C, Razali K, Tai R, Izenberg J, Rajan L, Van Griensven F, Kamarulzaman A. Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7.
    • Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend. 2011 Jan 11.
    2010
    • Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect. 2010 Aug 11. (ISI-Indexed)
    • Zahari MM, Bae WH, Zainal NZ, Habil H, Kamarulzaman A, Altice FL.Psychiatric and Substance Abuse Co-Morbidity Among HIV Seropositive and HIV Seronegative Prisoners in Malaysi. Am J Drug Alcohol Abuse.Jan;36(1);31-8
    • Yue Li, BSc,Kok Keng Tee, PhD,Huanan Liao,PhD,Saiki Hase, PhD,Rie Uenishi,PhD,Xiao-Jie Li, MD, PhD,Takayo Tsuchiura, BSc,Rongge Yang, MD, PhD,Sumathi Govindasamy, BA,Yean Kong Yong, MMedSc, Hong Yien Tan, MMedSc,Oliver G. Pybus, PhD,k Adeeba Kamarulzaman,MBBS, FRACP,and Yutaka Takebe, MD, PhD.Identification of a Novel Second-Generation Circulating .Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. Feb 2010
    • Zahari, M. M., Bae, W. H., Zainal, N. Z., Habil, H., Kamarulzaman, A., Altice, F. L. 2010. Psychiatric and Substance Abuse Comorbidity among HIV Seropositive and HIV Seronegative Prisoners in Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.335) (ISI-Indexed)
    • Takebe, Y., Liao, H. N., Hase, S., Uenishi, R., Li, Y. E., Li, X. J., Kamarulzaman, A., Tee, K. K., et al. 2010. Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: The relevance of genetic diversity and phylodynamics for vaccine strategies Vaccine. (Tier 1, Impact Factor = 3.616) (ISI-Indexed)
    • Zhou, J. L., Sirisanthana, T., Kiertiburanakul, S., ..., Kamarulzaman, A., et al. 2010. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.55) (ISI-Indexed)
    • Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., Friedland, G. H. 2010. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs Lancet. (Tier 1, Impact Factor = 30.758) (ISI-Indexed)
    • Fong, M. Y., Wong, K. T., Rohela, M., Tan, L. H., Adeeba, K., Lee, Y. Y., Lau, Y. L., et al. 2010. Unusual manifestation of cutaneous toxoplasmosis in a HIV-positive patient Tropical Biomedicine. (Tier 4, Impact Factor = 0.649) (ISI-Indexed)
    • Bux SI, Mohd. Ramli N, Ahmad Sarji S, Kamarulzaman A CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE Biomed Imaging Interv J 2010; 6(4):e35 (SCOPUS-Indexed)
    • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet . 2010 Jul 24;376(9737):208-11
    • Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to Act : a call for comprehensive responses to HIV in people who use drugs.Lancet.2010Jul 20
    • Altice FL,Kamarulzaman A, Soriano W,Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367-87
    • Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J,Sirisanthana T, Chen YM, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; on behalf of The TREAT Asia HIV Observational Databse. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010 Mar 21
    • Takebe Y, Liao H, Hase S, Uenishi R, Li Y, Li XJ, Han X, Shang H, Kamarulzaman A, Yamamoto N, Pybus OG, Tee KK. Reconstructing the chronology of the expansion of HIV-1 in East Asia: the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC. Vaccine. 2010 May 26;28 Suppl 2:B39-44.
    • Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010 Apr;84(7):3339-50. Epub 2010 Jan 20.
    • Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y. Identification of a Novel Second- Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. J Acquir Immune Defic Syndr. 2010 Apr 7.
    • Lau KA, Wang B, Miranda-Saksena M, Boadle R, Kamarulzaman A, Ng KP, Saksena NK. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res. 2010 Apr 1;8(3):259-71.
    • CE Lee, K Adeeba, G Freigang Human Plasmodium Knolesi Infections in Klang Valley, Peninsula Malaysia : A Case Series Med J Mal Vol 65 No 1 , March 2010
    • Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-28.
    • Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010 Jun;21 (6):416-23
    • Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy. 2010 Mar;21(2):115-8. Epub 2009 Dec 16.
    • Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S,Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.doi: 10.1111/j.1399- 0039.2010.01570.x. [Epub ahead of print] PubMed PMID: 20887379
    • Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1:102 doi:10.4172/2155-6113.1000102
    • Sam, I., Kamarulzaman, A., Ong, G., Veriah, R. S., Ponnampalavanar, S., Chan, Y. F., & AbuBakar, S. (2010). Research note chikungunya virus-associated death in Malaysia. Tropical biomedicine, 27(2), 343-347. (ISI-Indexed)
    • Adeeba Kamaruzzaman & Shaikh Mohd Saifuddeen. 2010. Islam and harm reduction. International Journal of Drug Policy 21(2): 115-118. (ISI-Indexed)
    2009
    • Kamarulzaman A, Impact of HIV Prevention Programs on Drug Users in Malaysia . J Acquir Immune Defic Syndr .Nov;52 Suppl 1;S17-9
    • Kamarulzaman A, Antiretroviral therapy in Malaysia; identifying barriers to universal access HIV Therapy. Nov , Vol. 3, No. 6, Pages 573-582
    • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re- emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2009 May;13(3):307-18.
    • Tee KK, Kusagawa S, Li XJ, Onogi N, Isogai M, Hase S, Uenishi R, Liao H, Kamarulzaman A, Takebe Y. Isolation and characterization of a replication- competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)PLoS One. Aug 18;4 (8).
    • Benito, N., Miro, J. M., de Lazzari, E., ..., Kamarulzaman, A., et al. 2009. Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition Annals of Internal Medicine. (Tier 1, Impact Factor = 17.457) (ISI-Indexed)
    • Tee, K. K., Pybus, O. G., Parker, J., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2009. Estimating the date of origin of an HIV-1 circulating recombinant form Virology. (Tier 2, Impact Factor = 3.539) (ISI-Indexed)
    • Zhou, J. L., Elliott, J., Li, P. C. K., ..., Kamarulzaman, A., et al. 2009. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.536) (ISI-Indexed)
    • Srasuebkul, P., Lim, P. L., Lee, M. P., ..., Kamarulzaman, A., et al. 2009. Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database Clinical Infectious Diseases. (Tier 1, Impact Factor = 8.266) (ISI-Indexed)
    • Cherry, C. L., Affandi, J. S., Imran, D., Yunihastuti, E., Smyth, K., Vanar, S., Kamarulzaman, A., Price, P. 2009. Age and height predict neuropathy risk in patients with HIV prescribed stavudine Neurology. (Tier 1, Impact Factor = 7.043) (ISI-Indexed)
    • Egger, S., Petoumenos, K., Kamarulzaman, A., Hoy, J., Sungkanuparph, S., Chutah, J., Falster, K., Zhou, J. L., Law, M. G. 2009. Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD) Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
    • Bruce, R. D., Govindasamy, S., Sylla, L., Kamarulzaman, A., Altice, F. L. 2009. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market American Journal of Drug and Alcohol Abuse. (Tier 3, Impact Factor = 1.094) (ISI-Indexed)
    • Kamarulzaman, A. 2009. Impact of HIV Prevention Programs on Drug Users in Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57) (ISI-Indexed)
    • Tee, K. K., Takebe, Y., Kamarulzaman, A. 2009. Emerging and re-emerging viruses in Malaysia, 1997-2007 International Journal of Infectious Diseases. (Tier 3, Impact Factor = 2.210) (ISI-Indexed)
    • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kone P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Mir JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct 27;168(19):2095-103 (ISI-Indexed)
    • Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV- infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50 (ISI-Indexed)
    • Benito N, Mir JM, de Lazzari E, Cabell CH, del R A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94 (ISI-Indexed)
    • Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.Estimating the date of origin of an HIV-1 circulating recombinant form.Virology. 2009 Mar 7.
    • Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009 Jul 28;73(4):315-20.
    2008
    • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
    • Sherman SG, Kamarulzaman A, Spittal P.Women and drugs across the globe: a call to action. Int J Drug Policy. 2008 Apr;19(2):97-8.
    • Baddley JW, Benjamin DK Jr, Patel M, Mir J, Athan E, Barsic B, Bouza E,Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D,Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis- Prospective Cohort Study Group (ICE - PCS).Eur J Clin Microbiol Infect . Candida infective endocarditis. Dis. 2008 Jul;27(7):519-29.
    • Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y.Chronology of the HIV- 1 CRF07_BC expansion in East Asia. AIDS. 2008 Jan 2;22(1):156-8.
    • Tee, K. K., Pybus, O. G., Liao, H., Uenishi, R., Hase, S., Kamarulzaman, A., et al. 2008. Chronology of the HIV-1CRF07_BC expansion in East Asia Aids. (Tier 1, Impact Factor = 5.842) (ISI-Indexed)
    • Baskaran, N. D., Gan, G. G., Adeeba, K. 2008. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients Annals of Hematology. (Tier 2, Impact Factor = 2.342) (ISI-Indexed)
    • Bruce, R. D., Govindasamy, S., Sylla, L., Haddad, M. S., Kamarulzaman, A., Altice, F. L. 2008. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.236) (ISI-Indexed)
    • Tan, D., Yong, Y., Tan, H., Kamarulzaman, A., Tan, L., Lim, A., et al. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis Hiv Medicine. (Tier 1, Impact Factor = 3.347) (ISI-Indexed)
    • Sherman, S. G., Kamarulzaman, A., Spittal, P. 2008. Women and drugs across the globe: A call to action International Journal of Drug Policy. (Tier 2, Impact Factor = 1.272) (ISI-Indexed)
    • Tee, K. K., Pybus, O. G., Li, X. J., Han, X. X., Shang, H., Kamarulzaman, A., et al. 2008. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia Journal of Virology. (Tier 1, Impact Factor = 5.332) (ISI-Indexed)
    • Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. 2008. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region Neurology. (Tier 1, Impact Factor = 6.014) (ISI-Indexed)
    • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2008. Continuous crossover(s) events of HIV-1CRF01_AE and B subtype strains in Malaysia: Evidence of rapid and extensive HIV-1 evolution in the region Current Hiv Research. (Tier 2, Impact Factor = 2.653) (ISI-Indexed)
    • 33.Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
    • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1139-45.
    • Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kamarulzaman A, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med. 2008 Oct 27; 168(19):2095-103
    • Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov 15;372(9651):1733-45
    • Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008 Sep;82(18):9206-15.
    • Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. Immunological Profiles of Immune Restoration Disease Presenting as Mycobacterial Lymphadenitis and Cryptococcal Meningitis. HIV Med. 2008 May;9(5):307-16
    • Wright E, Brew B, Arayawichanont A, Robertson k, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffman S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, dwyer R, McCormack G, Hellard M, Cherry C, Mc Arthur J, Wesselingh S. Neurologic Disorders are Prevalent in HIV-posotive Outpatients in the Asia-Pacific Region. Neurology. 2008 Jul 1;71(1):50-6.
    • Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altics FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. AM J Drug Alcohol Abuse. 2008;24(4):511-7
    • Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2008 Nov 13
    2007
    • Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology. 2007 Oct 25;367(2):288-97.
    • Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 2007 Jan;8(1):8-16.
    • Wang, B., Lau, K. A., Ong, L. Y., Shah, M., Steam, M. C., Foley, B., Dwyer, D. E., Chew, C. B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants Virology (ISI-Indexed)
    • Baskaran, N. D., Gan, G. G., Adeeba, K., Sam, I. C. 2007. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia International Journal of Infectious Diseases (ISI-Indexed)
    • Lim, A., Tan, D., Price, P., Kamarulzaman, A., Tan, H. Y., James, I., French, M. A. 2007. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy Aids (ISI-Indexed)
    • Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Near full-length sequence analysis of a unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
    • Reid, G., Kamarulzaman, A., Sran, S. K. 2007. Malaysia and harm reduction: The challenges and responses International Journal of Drug Policy (ISI-Indexed)
    • Zhou, J., Paton, N. I., Ditangco, R., Chen, Y. M., Kamarulzaman, A., Kumarasamy, N., Lee, C. K. C., Li, P. C. K., Merati, T. P., Phanuphak, P., Pujari, S., Vibhagool, A., Zhang, F., Chuah, J., Frost, K. R., Cooper, D. A., Law, M. G. 2007. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database Hiv Medicine (ISI-Indexed)
    • Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007 Jul 31;21(12):1525-34.
    • Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A. Emerging HIV Epidemics in Muslim Countries: Assessment of Different Cultural Responses to Harm Reduction and Implications for HIV Control. Cur HIV/AIDS Rep. 2007 Dec;4(4):151-7
    • Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007 Mar;18(2):136-40
    • Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007 Aug;18(4):306-12
    2006
    • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia Medical Microbiology and Immunology (ISI-Indexed)
    • Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
    • Raja, N. S., Parasakthi, N., Puthucheary, S. D., Kamarulzaman, A. 2006. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Journal of Postgraduate Medicine (ISI-Indexed)
    • Tee, K. K., Li, X. J., Nohtomi, K., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2006. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
    • Zhou, M. L., Phanupak, P., Kiertiburanakul, S., Ditangco, R., Kamarulzaman, A., Pujary, S., et al. 2006. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
    • Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
    • Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. J Postgrad Med. 2006 Jan-Mar;52(1):23-9;
    • Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):523-9.
    • Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4.
    • Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol. 2006 Jun;195(2):107-12.
    2005
    • Vinothini. A, Khoo, E.M. & Adeeba, K. 2005. Knowledge of HIV/AIDs in among pregnant women in an urban health clinic - a preliminary study. The Family Physician 13(1&2): 10-15 (Non-ISI/Non-SCOPUS)
    • Tee, K. K., Saw, T. L., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia Aids Research and Human Retroviruses (ISI-Indexed)
    • Tee, K. K., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia Aids (ISI-Indexed)
    • Joazlina, Z. Y., Wastie, M. L., Kamarulzaman, A. 2005. Kostmanns syndrome Clinical Imaging (ISI-Indexed)
    • Ranganathan, S., Moosa, F., Kamarulzaman, A., Looi, L. M. 2005. MRI and CT findings of cryptococcal vaginitis British Journal of Radiology (ISI-Indexed)
    • Zhou, J., Kumarasamy, N., Ditangco, R., Kamarulzaman, A., Lee, C. K. C., Li, P. C. K., et al. 2005. The TREAT Asia HIV observational database - Baseline and retrospective data Jaids-Journal of Acquired Immune Deficiency Syndromes (ISI-Indexed)
    • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50.
    • Adeeba Kamarulzaman .Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. 2005, Med. J. Malaysia, Vol. 60, no. 1, pg. 1-4
    • Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG, The TREAT Asia HIV Observational Database: Baseline and Retrospective Data, 2005, J. Acquir. Immune Defic. Syndr., Vol. 138, no. 2, pg. 174-179
    • Ranganathan S, Moosa F, Kamarulzaman A, Looi LM. MRI and CT findings of cryptococcal vaginitis. 2005, Br. J. Radiol., Vol. 78, no. 928, pg. 353-354
    • Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS. 2005 Jan 28;19(2):119-26.
    • Joazlina ZY, Wastie ML, Kamarulzaman A. Kostmann's syndrome. Clin Imaging. 2005 Sep-Oct;29(5):364-6.
    • Nurul Atifah MA, Loo HK, Subramaniam G, Wong EH, Selvi P, Ho SE, Kamarulzaman A, Parasakthi N. Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients. Malays J Pathol. 2005 Dec;27(2):75-81.
    • Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50.
    • Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005 Jan;26(1):100-4.
    2004
    • Kamarulzaman A. Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Healt. 2004;16(1):1-2
    • Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7.
    • Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004 Jun 1;38(11):1570-8
    • Oh WS, Suh JY, Song JH, Ko KS, Jung SI, Peck KR, Lee NY, Yang Y, Chongthaleong A, Chiu CH, Kamarulzaman A, Parasakthi N, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Carlos CC; ANSORP Study Group. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist. 2004 Spring;10(1):37-42
    2002
    • Tan, Y. M., Goh, K. L., Kamarulzaman, A., Tan, P. S., Ranjeev, P., Salem, O., et al. 2002. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate Gastrointestinal Endoscopy (ISI-Indexed)
    • Tan, L. H., Kamarulzaman, A., Liam, C. K., Lee, T. C. 2002. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Infection Control and Hospital Epidemiology (ISI-Indexed)
    • Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia. 2002 Sep;57(3):304-10.
    • Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol. 2002 Oct;23(10):584-90.
    • Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, Vasudevan AE, Rosaida MS, Rosmawati M, Tan LH. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002 Feb;55(2):276-8.
    • Gan GG, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia. 2002 Mar;57(1):118-22.
    2001
    • Chua, K. B., Lam, S. K., Goh, K. J., Hooi, P. S., Ksiazek, T. G., Kamarulzaman, A., Olson, J., Tan, C. T. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia Journal of Infection (ISI-Indexed)
    • Chong, H. T., Kamarulzaman, A., Tan, C. T., Goh, K. J., Thayaparan, T., Kunjapan, R., Chew, N. K., Chua, K. B., Lam, S. K. 2001. Treatment of acute Nipah encephalitis with ribavirin Annals of Neurology (ISI-Indexed)
    • Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3.
    • Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001 Jan;42(1):40-3.
    2000
    • Goh, K. J., Tan, C. T., Chew, N. K., Tan, P. S. K., Kamarulzaman, A., Sarji, S. A., et al. 2000. Clinical features of nipah virus encephalitis among pig farmers in Malaysia New England Journal of Medicine (ISI-Indexed)
    • Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 2000 Nov;32(7):1965-6.
    • Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, Chew NK, Tan KS, Kamarulzaman A, Wong KT. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000 Nov;48(5):802-5.
    • Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35.
    1999
    • Pakianathan MR, Kamarulzaman A, Ismail R, McMillan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS. 1999 Sep 10;13(13):1787-8. No abstract available
    • Chua, K. B., Goh, K. J., Wong, K. T., Kamarulzaman, A., Tan, P. S. K., Ksiazek, T. G., et al. 1999. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia Lancet (ISI-Indexed)
    • Pakianathan, M. R., Kamarulzaman, A., Ismail, R., McMillan, A., Scott, G. R. 1999. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients Aids (ISI-Indexed)
    • Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999 Oct 9;354(9186):1257-9
    1996
    • Kamarulzaman A, Briggs RJ, Fabinyi G, Richards MJ. Skull osteomyelitis due to Salmonella species: two case reports and review. Clin Infect Dis. 1996 Apr;22(4):638-41.
    Book
    2009
    • Is It HIV ? A handbook for healthcare providers. Australasian Soceity for HIV Medicine & Treat Sia . 2009, Editor
    2004
    • Rapid Situation Assessment of Malaysia 2004, G Reid, A Kamarulzaman, S Kaur . 1-41
    • University Hospital Antibiotic Policy and Guidelines 2004 - 2006 . Editors A kamarulzaman , N Parasaktthi
    2000
    • Consensus Guidelines on the Management of Staphylococcus aureus infections . Editor A Kamarulzaman . April 2000
    1998
    • 1st National Consensus Guidelines on Antiretroviral Therapy. October 1998 Editors C Lee, A Kamarulzaman, M Alias, N Othman
    Book Chapter
    2016
    • Ng CW, Mohd Hairi NN, Ng CJ, Kamarulzaman A. 2016. Universal Health Coverage in Malaysia: Issues and Challenges. In Tey NP, Cheong KC, Rasiah R (eds). Revisiting Malaysia's Population-Development Nexus. The Past in Its Future. Kuala Lumpur: University of Malaya Press.
    2008
    • A Kamarulzaman, K Razali. The HIV epidemic in Malaysia. Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care. Editors C Beyrer, D Celentano Springer, New York 2008.
    2006
    • A Kamarulzaman. Sepsis. Management aspects of acute care. Eds: Chan YK, Ng KP. 2006:179-187
    • P du Cros, A Kamarulzaman. HIV and Tuberculosis Coinfection. Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Editor: M Curtis. International Harm Reduction Development Program. Open Society Institute. 2006
    2002
    • A Kamarulzaman. Common viral infections in Aisa . Principles and Practice of clinical Medicine in Asia. Treating the Asian Patient. Eds : JJY Sung, LKS Wong, PKT Li, J Sanderson, TCY Kwok. 2nd Edn : 2002
    1995
    • A Kamarulzaman, J Hoy. Cryptosporidia and microsporidia. In Fairfield Hospital HIV Handbook. Eds: F Bowden, A Mijch 1995; 43-44
    Mass Media(Newspaper,Radio,TV,Popular Magazine)
    2015
    • Rawatan penagih lebih baik di luar penjara
    • Malay Mail - Monash Honarary Doctorate Award
    • Her World Power list: 6 most inspiring women of Singapore and Malaysia
    2014
    • Metro Ahad / Karisma
    2013
    • Adeeba Kamarulzaman,Reena Rajasuriar
    • Foundation receives RM25,000 - NST
    • The female face of HIV/AIDS
    • AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL
    • FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE CLOSE TO HER HEART
    • THE THIN RED LINE
    • Adeeba Kamarulzaman and Bertrand Union . Winds of change on drug policy
    • Adeeba Kamarulzaman. Penghidap HIV turun
    2012
    • New York Times : Towards an AIDS-Free World
    Others
    1999
    • A Kamarulzaman, KJ Goh. Causes of viral encephalitis outbreaks in Malaysia and Australia. In UptoDate. Eds JG Bartlett, SB Calderwood, MS Hirsch, et al. 1999 - Electronic Publication
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    RU Operation
  • Review Of Policy Towards Healthy Lifestyles, Co-Researcher, 2015 - 2017 (National)
  • National Medical Research Council (NMRC) Singapore
  • Adult Dengue Platelet Study (ADEPT), Consultant, 2013 - 2015 (International)
  • High Impact Research (HIR)
  • Molecular Genetics of Respiratory Pathogens Associated with Respiratory Tract Infections (From January 2012) High Impact Research (HIR): Genetics of the Respiratory, Gastrointestinal, Central Nervous System and Blood-borne Pathogens , Consultant, 2012 - 2014
  • HTMC, Flag ship
  • Diseases among poverty (A community based participatory action research project) , Consultant, 2011 - 2012 (National)
  • Strengthening Epidemic Intelligence in Malaysia , Principal Investigator(PI), 2011 - 2011
  • WHO
  • A Multicentre Study To Validate The Predictive Value Of Warning Signs In Dengue , Consultant, 2011 - 2011 (International)
  • Pfizer
  • A phase 2B multicenter, randomized, comparative trial of UK-453.061 versus etravirine in combination with Darunavir/Ritonavir and a Nucleotide/Nucleoside reverse transcriptase inhibitor for the treatment of antiretroviral experienced HIV-1 infected subjects with evidence of NNRTI 0resistant HIV-1. A phase 2B/3 open-label rollover study for subjects discontinuing from the UK-453,061 protocols for the treatment of HIV-1 infected subjects. Sponsor : Pfizer , Principal Investigator(PI), 2010 - 2012 (National)
  • Linezolid In The Treatment of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus Protocol: A5951001 , Co-Researcher, 2004 - 2008
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • A prospective observational cohort study of immune reconstitution and its consequences in immunodeficient HIV-infected patients treated with highly active anti-retroviral therapy. , Consultant, 2009 - 2011 (National)
  • Social Determinants Epidemiological Routes of HIV/STI transmission Among Fishermen , Principal Investigator(PI), 2009 - 2011 (National)
  • Pilot Project: Introducing Methadone and HAART for Soon To Be Released HIV-Positive Prisoners in Pengkalan Chepa Kelantan , Consultant, 2008 - 2008 (National)
  • A cross sectional survey and prospective study on tuberculin skin reaction among healthcare workers at University Malaya Medical Centre , Consultant, 2001 - 2008
  • NCHECR, University of New South Wales
  • A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study , Consultant, 2008 - 2008
  • PFIZER Inc
  • A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B followed by fluconazole in the treatment of candidaemia in non neutropaenic subjects , Consultant, 2008 - 2008
  • ICE
  • International Collaboration on Endocarditis (ICE) Prospective Cohort Study of Infective Endocarditis , Consultant, 2008 - 2008
  • Smith-Kline Beecham International
  • An open non-comparative, multicentre study to assess the efficacy and safety of oral SB 265805 320 mg once daily for 7 days for the treatment of lower respiratory tract infections in adults. Sponsor: Smith-Kline Beecham International , Consultant, 2008 - 2008
  • National Institutes on Drug Abuse, USA
  • Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Sponsor: National Institutes on Drug Abuse, USA , Principal Investigator(PI), 2008 - 2008
  • Pharmaceutical company (Pfizer)
  • ZEPHYR study , Principal Investigator(PI), 2008 - 2008 (International)
  • ScienceFund
  • Genotypic and Phenotypic Characterization of Novel Human Immunodeficiency Virus Type 1 (HIV-1) Circulating Recombinant Form (CRF33_01B) in Malaysia , Principal Investigator(PI), 2007 - 2008
  • NCHECR, University of New South Wales
  • A randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Conmbinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study , Principal Investigator(PI), 2006 - 2012 (International)
  • TREAT Asia
  • Monitoring and Evaluation of HIV Drug Resistance in Patients on Antiretroviral Therapy. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER M. , Consultant, 2006 - 2008 (International)
  • Evaluation of Transmitted HIV Drug Resistance in Treatment Na ve, Recently Infected HIV Individuals. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER S , Consultant, 2006 - 2008
  • Tibotec
  • A randomized, controlled, open label-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment- experienced HIV-infected subjects Protocol: TMC114-214 , Consultant, 2005 - 2008
  • Japan Foundation for AIDS Prevention
  • International collaborative study on epidemiological survey of HIV infections, isolation and characterisation of unique HIV-1 recombinants emerging in Malaysia. , Principal Investigator(PI), 2005 - 2008
  • GSK
  • A prospective randomized, double-blind, placebo- controlled, dose ranging, multi-center study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram negative severe sepsis in adults , Consultant, 2004 - 2008
  • University of Western Australia
  • Immune Reconstitution Disease in Severely Immuno- deficient AIDS patients commencing HAART Collaborator: University of Western Australia , Principal Investigator(PI), 2004 - 2008
  • National Institute of Health, USA
  • A Multi-faceted Study of HIV in Malaysia CIPRA R03 AI 56379-01 , Principal Investigator(PI), 2003 - 2008
  • amfAR
  • TREAT Asia Observational Database , Consultant, 2003 - 2008
  • Eli - Lily
  • LY333328 versus vancomycin in complicated skin/skin-structure infections. Protocol H4Q-MC-ARRI , Consultant, 2001 - 2008
  • Bristol-Myers Squibb
  • A Phase 111 study comparing the antiviral efficacy and safety of BMS-232632 with efavirenz, each in combination with fixed dose zidovudine-lamivudine , Consultant, 2000 - 2008
  • ANSORP
  • Clinical impact of antimicrobial resistance among invasive pneumococcal pathogens in Asian countries , Consultant, 2000 - 2008
  • Sarawak Medichem Pharmaceuticals
  • A Phase 1B Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV Positive Patients with No Previous Antiretroviral Therapy , Consultant, 1999 - 2008 (National)
  • IRPA
  • Prophylactic versus pre-emptive therapy of cytomegalovirus infection in bone marrow and solid organ transplant patients , Principal Investigator(PI), 1999 - 2008
  • Grunenthal Gmbh
  • Efficacy and Safety of Oral Gatifloxacin versus oral amoxacillin with a treatment duration of 7 to 10 days in patients with bacterial community acquired pneumonia , Consultant, 1999 - 2008
  • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Ongoing
    • PhD, Dr Salwa Mudddthir Ismail Norien (Post Graduate Student)
    • PhD, Yong Yean Kong (Post Graduate Student)
    • MSC, Martin Choo (Post Graduate Student)
    • MSC, Tunku Noor Hayati Binti Tunku Abdul Rahman (Post Graduate Student)
    • MMed, Dr Azureen Azmel (Post Graduate Student)
    • PhD, Tan Hong Yien (Post Graduate Student)
    Completed
    • MMed, Dr Sufian Adnan (Post Graduate Student)
    • ADVANCED TRAINING IN INFECTIOUS DISEASES, Dr James Koh (Post Graduate Student)
    • ADVANCED TRAINING IN INFECTIOUS DISEASES, Dr Leong Chee Loong (Post Graduate Student)
    • PhD, Tee Kok Keng (Post Graduate Student)
    • MMed, Dr Wong Chew Ming (Post Graduate Student)
    • MMed, Dr Muhammad Zainafyah Bin Zakaria (Post Graduate Student)
    • MMed, Dr Sufian Adnan (Post Graduate Student)
    • MMed, Dr Sufian Adnan (Post Graduate Student)
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Malaysian AIDS Foundation Board of Trustees, 14/05/2018 to 13/05/2020
    • Speciality Subcommittee Infectious Disease - Committee Member, 04/01/2016 to 03/01/2018
    • Angggota Majlis Penasihat Program Jelajah Kaseh Orang Muda OKB derma Organ Demi Kehidupan, 2021
    • Perlantikan sebagai External Reviewer bagi garis panduan Antibiotik Kebangsaan 2014, 2021
    • 20th International AIDS Conference Melbourne, Australia - Editors Reviewers, 20/07/2014 to 25/07/2014
    • Ahli Majlis Perubatan Malaysia, 22/12/2013 to 21/12/2016
    • Ahli Panel Pakar Bidang Perubatan Dan Sains Kesihatan, 19/02/2013 to 18/02/2015
    • Subspeciality Training Subcommittee, 28/09/2012 to 27/09/2014
    • National Specialist Register, 2021
    • Panel Penilai Pakar untuk Penilaian Permohonan Pembiayaan dan Pemantauan Dana R, D&C Kementerian Sains, teknologi dan Inovasi (MOSTI), 01/03/2012 to 31/12/2015
    • Executive Committee, Malaysian AIDS Council, 01/01/2010 to 31/12/2016
    • Vice-Chair, Country Coordinating Mechanism, The Malaysian Global Fund Initiative ., 01/01/2009 to 31/07/2009
    • Member, National Health Promotions Board, 01/01/2008 to 01/04/2010
    • Malaysian AIDS Foundation - Chairman, 01/01/2006 to 31/12/2016
    • President Malaysian AIDS Council, 01/01/2006 to 01/04/2010
    • Member, National Task Force on Harm Reduction, Ministry of Health Malaysia, 2021
    • Member, National Infection Control and Antibiotic Committee, Ministry of Health, 2021
    • Convenor, Malaysian Harm Reduction Working Group, 2021
    ACADEMIC/PROFESSIONAL SERVICES
    Expert Linkages
    (Linkages Description),(Organisation),(Duration of Involvement),(Level)
  • Scientific Exchange Program , Global Health Equity Scholars - Yale university , 2016 (International)
  • PhD Selection Committee Pasteur-Paris Institute, Pasteur Institute, Paris , 2014 (International)
  • Student Exchange Program , Yale university , 2013 (International)
  • Co-chairperson, Scientific Program Committee International AIDS Conference, Vienna 2010, International AIDS Society , 2010 (International)
  • Member, Oversight Committee for the Second Independent Evaluation of UNAIDS, UNAIDS, 2008 (International)
  • Executive Committee Member, International Society for Infectious Diseases (ISID), 2008 (International)
  • Member, United Nations Reference Group on HIV and Injecting Drug Use, United Nations , 2007 (International)
  • Advisory Board Member, UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, UNAIDS, 2006 (International)
  • Member, United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, United Nations, 2006 (International)
  • Advisory Board Member, International Harm Reduction Development, International Harm Reduction Development, 2006 (International)
  • Vice-Chair, Global Initiatives Committee- Foundation for AIDS Research (amfAR), amfAR, 2006 (International)
  • Executive Committee Member, International Harm Reduction Association, International Harm Reduction Association, 2006 (International)
  • Steering Committee Member, Asian Network on Surveillance of Resistant Pathogens (ANSORP), ANSORP, 2005 (International)
  • Steering Committee Member. TREAT Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. American Foundation for AIDS Research (amfAR), amfAR, 2005 (International)
  • Member, Technical Expert Panel - UNAIDS Regional Task Force on IDU, consultative meeting, UNAIDS, 2005 (International)
  • Member, Expert Panel - National Consensus Guidelines for the Management of Extended-spectrum Beta-Lactamase Producing Bacteria, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001 (National)
  • Co-Chairperson - Consensus meeting on the use of antiretroviral therapy in Malaysia, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 2001 (National)
  • Chairperson - Consensus Guidelines on the management of Staphylococcus aureus infections, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, 1999 (National)
  • Member, Expert Panel - Consensus on the use of antiretroviral therapy in emerging nations, BMS, 1998 (International)
  • Academic/Technical Contribution
    (Activity),(Organisation),(Duration),(Role)
  • Member, National Health Advisory Committee, Ministry of Health Malaysia, 2018 - 2020 (Committee Member)
  • Board of Director , Clinical Research Malaysia, 2017 - 2019 (Advisor)
  • Board Member , UMMC, 2011 - 2020 (Advisor)
  • Board Member , UMSC , 2011 - 2020 (Advisor)
  • Country Coordinating Mechanism , The Malaysian Global Fund, Country Coordinating Mechanism , The Malaysian Global Fund , 2009 - Present (Vice Chair / Member)
  • Chairman , Malaysian AIDS Foundation , 2006 - 2020 (Chairman)
  • Board Member , Malaysian AIDS Council , 2006 - 2020 (Expert Advisor)
  • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • SIJIL PENGHARGAAN KEPADA PANEL PAKAR PENASIHAT PIHAK BERKUASA KAWALAN DADAH, PIHAK BERKUASA KAWALAN DADAH, KKM, 2019
    • President-Elect , International AIDS Society, 2018
    • Certificate of Appreciation, Perdana University, 2018
    • University Malaya, University Malaya, 2017
    • , SULTAN PERAK, 2016
    • Honarary Doctorates, Monash University, 2015
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2014
    • Top Research Scientists Malaysia, Akademi Sains Malaysia, 2014
    • Certificate of Credentialing & Privileging, University Malaya, 2013
    • UM EXCELLENCE AWARD, NAIB CANSELOR, 2012
    • Sijil Penghargaan - Jawatankuasa Majlis Penilaian Teknologi Kesihatan Dan Panduan Amalan Klinikal, Kementerian Kesihatan Malaysia, 2012
    • Anugerah Cermerlang Universiti Malaya 2012, University Malaya, 2012
    • Australian Education Achievement Award 2012 ( Winner - Alumni Category ), Australian High Commissioner, Kuala Lumpur, 2012
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2011
    • Finalis Anugerah Perdana Menteri Penggiat Sosial Wanita 2011, Menteri Pembangunan Wanita, Keluarga dan Masyarakat, 2011
    • 50 Emerging Women Leader in Asia Pacific 2011 Advance Australia, Australian Government, 2011
    • Pingat Bakti Setia Jabatan Penjara Malaysia, Jabatan Penjara Malaysia, 2009
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2008
    • Merdeka Award, Exxon Mobil, Petronas and Shell, 2008
    • Tun Mahathir Science Award, Malaysian Academy of Science, 2008
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2007
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2006
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2005
    • Swarovski Life Ball Crystal of Hope Award, Austrian Life Ball, 2005
    • Australian-Asian Fellowship Award, Australian Government, 2002
    • International AIDS Fellowship Programme, International Society of Infectious Diseases, 1999
    • Fellow in Infectious Diseases, Senior Medical Staff, Fairfield Hospital, 1995
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Antibiotics prescribing practices of upper respiratory tract infections in primary care, MOSTI, 01/12/2003 to 01/12/2003 (National)
    • WHO 2013 Consolidated guidelines on the use of antiretroviral for the treatment and prevention of HIV , WHO, 01/09/2013 to 01/09/2013 (International)
    • Consultation on Ethics in Conducting Research in People Who Use Drugs 2 - UNAIDS, WHO. Kuala Lumpur , December 2010, WHO, 01/01/2010 to 01/01/2010 (International)
    • Institute of Medicine, National Academies of Sciences, USA. Prevention of HIV Infection among Injecting Drug Users in High Risk Countries An Assessment of the Evidence. , Institute of Medicine, National Academies of Sciences, USA, 01/09/2005 to 01/09/2005 (International)
    • World Health Organisation. HIV Testing and Counselling. Phnom Penh, World Health Organisation, 01/09/2007 to 01/09/2007 (International)
    • World Health Organisation. HIV Testing and Counselling in IDU. Manila, World Health Organisation, 01/09/2007 to 01/09/2007 (International)
    • Global Advocacy for Injecting Drug Use Bill and Melinda Gates Foundation, London, Bill and Melinda Gates Foundation, 01/09/2008 to 01/09/2008 (International)
    • Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015 Confronting HIV Among People Who Inject Drugs Kuala Lumpur, -, 01/09/2009 to 01/09/2009 (International)
    • Consultation on Ethics in Conducting Research in People Who Use Drugs- UNAIDS. Istanbul, UNAIDS, 01/09/2010 to 01/09/2010 (International)
    • Visiting Consultant Physician, Institut Jantung Negara, 01/09/2000 to 01/09/2002 (National)
    • Confronting HIV among people who Inject Drugs - Kuala Lumpur Dec 09, Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015 , 01/04/2009 to 01/04/2009 (International)
    • ASEAN Workshop for the Exchange of Experience on Increasing Access to Treatment and Care for PLWHA, APCASO, 01/11/2002 to 01/11/2002 (International)
    • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, ASEAN, 01/11/2002 to 01/11/2002 (International)
    • ASEAN Workshop for the Exchange of Information on Increasing Access to HIV/AIDS Drug, APCASO, 01/11/2002 to 01/11/2002 (International)
    • Special Session on HIV/AIDS. New York., United Nations General Assembly, 01/11/2001 to 01/11/2001 (International)
    • UK Department for International Development HIV-AIDS Project. Towards a Strategy for Commonwealth Universities Geneva., Association of Commonwealth Universities, 01/11/2001 to 01/11/2001 (International)
    • United Nations General Assembly Special Session on HIV/AIDS, United Nations, 01/11/2001 to 01/11/2001 (International)
    • WHO Global Strategy for Containment of Antimicrobial Resistance Geneva., World Health Organisation, 01/11/2000 to 01/11/2000 (International)
    • Workshop on Notifiable Diseases., Ministry of Health Malaysia, 01/11/2000 to 01/11/2000 (National)
    • ASEAN Forum on HIV/AIDS. Port Dickson., Ministry of Health Malaysia, 01/11/2001 to 01/11/2001 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    PLEANARY SPEAKER
  • Substance Abuse and Harm Reduction, XVII International AIDS Conference August 2008. Mexico City., 01/08/2008 (International)
  • INVITED SEMINAR
  • , Seminar on Rights and Responsibilities of Government Doctors, 03/11/2012 to 03/11/2012, SCHOMOS / MOH (National)
  • , The First ASEANS Deans' Summit : Connecting ASEAN Medical Schools towards One Community" - International Conference in Medicine and Public Health (ICMPH) 2012, 17/09/2012 to 17/09/2012, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand (International)
  • INVITED SPEAKER
  • Population Approach to HIV Prevention & Control, The 5th AHLA International Health Literacy Conference, 12/11/2017 to 14/11/2017, Centre for Population Health (CePH), Dept of Social and Preventive Medicine, Faculty of Medicine, UM (National)
  • Malaysian Society for Molecular Biology and Biotechnology, 22nd Annual MSMBB Scientific Meeting, 08/09/2015 to 09/09/2015, Malaysian Society for Molecular Biology and Biotechnology (National)
  • Towards A Unified Approach to Patient Safety : The ASEAN Perspective, 1st ASEAN Patient Safety Congress, 25/06/2015 to 26/06/2015, UP College of Medicine
  • , 7th National Infectious Diseases Seminar and Workshop (NIDSAW)2012, 06/11/2013 to 06/11/2013, Universiti Putra Malaysia (National)
  • Accreditation on Medical School, Summit on Medical Education 2013, 23/08/2013 to 23/08/2013, University Teknologi MARA (National)
  • International Collaboration & Getting to Zero, 26th Annual Japan HIV Conference , 24/11/2012 to 26/11/2012, Japanese Society for AIDS Research (International)
  • Viral Hepatitis and HIV Coinfection, Singapore AIDS COnference, 17/11/2012 to 17/11/2012, Singapore AIDS Conference (International)
  • AIDS in Asia at the symposia on HIV , 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , 25/10/2012 to 28/10/2012, 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID)  (International)
  • HIV and Mobility, Asia Pacific Conference in Medical Virology 2012 , 06/06/2012 to 08/06/2012, APCMV 2012 Congress (International)
  • HIV care under universal coverage:challenges and choices, Global Public Health International Symposium on "Universal Coverage", 03/10/2011 to 01/10/2011, Monash University (International)
  • HIV and AIDS in Muslim Countries, Women In Science and Technology in Muslim Countries , 21/09/2011, MOSTI (National)
  • , 5th National Conference for Clinical Research 2011, 22/06/2011 to 24/06/2011, Ministry of Health Malaysia (National)
  • HIV Prevention in Malaysia, Global Health Centre, Columbia University, Almaty, Kazakshtan. May 2010. HIV Prevention in Malaysia, 31/05/2010 to 31/05/2010, Columbia University (International)
  • Monash University Malaysia Graduation Address, Monash University Malaysia Graduation Address, 10/04/2010 to 10/04/2010, Monash University  (International)
  • Carbapenem-resistant Pseudomonas and Acinetobacter, 13th International Congress in Infectious Diseases (ICID). Kuala Lumpur, 23/06/2008, International Society of Infectious Diseases (International)
  • PRESENTER
  • Two decades of harm reduction in Malaysia, The 27th IFNGO World Conference, 06/11/2017 to 08/11/2017, IFNGO - International Federation of Non - Government Organizations for the Prevention of Drug and Substance Abuse (International)
  • , Islam and HIV/AIDS International Conference 2012, 19/11/2013 to 21/11/2013, Department of Islamic Development Malaysia (National)
  • OTHERS
  • , MMA SECOND SEMINAR ON POSTGRADUATE MEDICAL EDUCATION, 26/01/2013 to 26/01/2013, Malaysian Medical Association (National)
  • Substance Abuse and Harm Reduction in Malaysia, XV111 International AIDS Conference July 2010. Vienna. Substance Abuse and Harm Reduction in Malaysia, 17/07/2010 to 24/07/2010, International AIDS Society (International)
  • Respondent Driven Sampling Involving the Community, XV111 International AIDS Conference July 2010. Vienna. Respondent Driven Sampling Involving the Community, 17/07/2010 to 24/07/2010, International AIDS Society (International)
  • Scalling up Harm Reduction in Malaysia, XIII th International Congress of AIDS in Asia and the Pacific (ICAAP)Aug 2009, 01/08/2009, AIDS Soceity Asia Pacific (International)
  • International Experience of Harm Reduction, Xth International Conference of Drug Dependence. Xian, China. October 2008, 01/10/2008, The Chinese Society of Addiction Medicine  (International)